Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
It is asking to be supported
Tirzepatide 10mg Lyophilized powder 39-amino acid dual GIP/GLP-1 receptor agonist studied in the SURPASS and SURMOUNT trial programs with over 15,000 participants
Please advise each eligible Medicare Part D or other applicable government insured patient using the self-pay offer that they must not submit the purchase for inclusion in any insurance benefit out-of-pocket spending calculations, such as Medicare Part D True Out-of-Pocket Costs (TrOOP)
The perceived value of such models also increased among both payers and employers alike
Moreover, partnerships between e-pharmacy platforms and drug manufacturers in 2025 have accelerated the availability of oral GLP-1 therapies across wider geographies
Most people begin to see weight loss within four to eight weeks after reaching their target dose, which might take several weeks due to gradual dose increases
